217 related articles for article (PubMed ID: 32950072)
1. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial.
Eisen DP; Leder K; Woods RL; Lockery JE; McGuinness SL; Wolfe R; Pilcher D; Moore EM; Shastry A; Nelson MR; Reid CM; McNeil JJ; McBryde ES
Lancet Respir Med; 2021 Feb; 9(2):186-195. PubMed ID: 32950072
[TBL] [Abstract][Full Text] [Related]
2. AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol.
Eisen DP; Moore EM; Leder K; Lockery J; McBryde ES; McNeil JJ; Pilcher D; Wolfe R; Woods RL
BMJ Open; 2017 Jan; 7(1):e013636. PubMed ID: 28110287
[TBL] [Abstract][Full Text] [Related]
3. Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial.
Zoungas S; Zhou Z; Owen AJ; Curtis AJ; Espinoza SE; Ernst ME; Woods RL; Orchard SG; McNeil JJ; Murray AM; Nelson MR; Reid CM; Ryan J; Wolfe R
Lancet Diabetes Endocrinol; 2024 Feb; 12(2):98-106. PubMed ID: 38142708
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of low-dose aspirin for the prevention of fractures in healthy older people: protocol for the ASPREE-Fracture substudy.
Barker AL; McNeil JJ; Seeman E; Ward SA; Sanders KM; Khosla S; Cumming RG; Pasco JA; Bohensky MA; Ebeling PR; Woods RL; Lockery JE; Wolfe R; Talevski J;
Inj Prev; 2016 Aug; 22(4):297-301. PubMed ID: 26002770
[TBL] [Abstract][Full Text] [Related]
5. Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical Trial.
Barker AL; Morello R; Thao LTP; Seeman E; Ward SA; Sanders KM; Cumming RG; Pasco JA; Ebeling PR; Woods RL; Wolfe R; Khosla S; Hussain SM; Ronaldson K; Newman AB; Williamson JD; McNeil JJ
JAMA Intern Med; 2022 Dec; 182(12):1289-1297. PubMed ID: 36342703
[TBL] [Abstract][Full Text] [Related]
6. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
Burn J; Sheth H; Elliott F; Reed L; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar R; Seppälä T; Thomas HJW; Pylvänäinen K; Borthwick GM; Mathers JC; Bishop DT;
Lancet; 2020 Jun; 395(10240):1855-1863. PubMed ID: 32534647
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
[TBL] [Abstract][Full Text] [Related]
8. Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial.
Islam RM; Bell RJ; Handelsman DJ; McNeil JJ; Nelson MR; Reid CM; Tonkin AM; Wolfe RS; Woods RL; Davis SR
Lancet Healthy Longev; 2022 Feb; 3(2):e109-e118. PubMed ID: 35252940
[TBL] [Abstract][Full Text] [Related]
9. Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.
Schisterman EF; Silver RM; Lesher LL; Faraggi D; Wactawski-Wende J; Townsend JM; Lynch AM; Perkins NJ; Mumford SL; Galai N
Lancet; 2014 Jul; 384(9937):29-36. PubMed ID: 24702835
[TBL] [Abstract][Full Text] [Related]
10. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.
ASPREE Investigator Group
Contemp Clin Trials; 2013 Nov; 36(2):555-64. PubMed ID: 24113028
[TBL] [Abstract][Full Text] [Related]
11. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
Ryan J; Storey E; Murray AM; Woods RL; Wolfe R; Reid CM; Nelson MR; Chong TTJ; Williamson JD; Ward SA; Lockery JE; Orchard SG; Trevaks R; Kirpach B; Newman AB; Ernst ME; McNeil JJ; Shah RC;
Neurology; 2020 Jul; 95(3):e320-e331. PubMed ID: 32213642
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.
Nelson MR; Reid CM; Ames DA; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Krum H; Storey E; Tonkin A; Wolfe R; Woods R; McNeil JJ
Med J Aust; 2008 Jul; 189(2):105-9. PubMed ID: 18637782
[TBL] [Abstract][Full Text] [Related]
13. Effect of Aspirin on Disability-free Survival in the Healthy Elderly.
McNeil JJ; Woods RL; Nelson MR; Reid CM; Kirpach B; Wolfe R; Storey E; Shah RC; Lockery JE; Tonkin AM; Newman AB; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Ryan J; Radziszewska B; Grimm R; Murray AM;
N Engl J Med; 2018 Oct; 379(16):1499-1508. PubMed ID: 30221596
[TBL] [Abstract][Full Text] [Related]
14. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Gaziano JM; Brotons C; Coppolecchia R; Cricelli C; Darius H; Gorelick PB; Howard G; Pearson TA; Rothwell PM; Ruilope LM; Tendera M; Tognoni G;
Lancet; 2018 Sep; 392(10152):1036-1046. PubMed ID: 30158069
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
[TBL] [Abstract][Full Text] [Related]
16. Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial.
Berk M; Woods RL; Nelson MR; Shah RC; Reid CM; Storey E; Fitzgerald S; Lockery JE; Wolfe R; Mohebbi M; Dodd S; Murray AM; Stocks N; Fitzgerald PB; Mazza C; Agustini B; McNeil JJ
JAMA Psychiatry; 2020 Oct; 77(10):1012-1020. PubMed ID: 32492080
[TBL] [Abstract][Full Text] [Related]
17. Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trial.
Mahady SE; Margolis KL; Chan A; Polekhina G; Woods RL; Wolfe R; Nelson MR; Lockery JE; Wood EM; Reid C; Ernst ME; Murray A; Thao L; McNeil JJ
Gut; 2021 Apr; 70(4):717-724. PubMed ID: 32747412
[TBL] [Abstract][Full Text] [Related]
18. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
Hoffman MK; Goudar SS; Kodkany BS; Metgud M; Somannavar M; Okitawutshu J; Lokangaka A; Tshefu A; Bose CL; Mwapule A; Mwenechanya M; Chomba E; Carlo WA; Chicuy J; Figueroa L; Garces A; Krebs NF; Jessani S; Zehra F; Saleem S; Goldenberg RL; Kurhe K; Das P; Patel A; Hibberd PL; Achieng E; Nyongesa P; Esamai F; Liechty EA; Goco N; Hemingway-Foday J; Moore J; Nolen TL; McClure EM; Koso-Thomas M; Miodovnik M; Silver R; Derman RJ;
Lancet; 2020 Jan; 395(10220):285-293. PubMed ID: 31982074
[TBL] [Abstract][Full Text] [Related]
19. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Taha AS; McCloskey C; McSkimming P; McConnachie A
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836
[TBL] [Abstract][Full Text] [Related]
20. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.
McNeil JJ; Nelson MR; Woods RL; Lockery JE; Wolfe R; Reid CM; Kirpach B; Shah RC; Ives DG; Storey E; Ryan J; Tonkin AM; Newman AB; Williamson JD; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Orchard SG; Trevaks RE; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Radziszewska B; Grimm R; Murray AM;
N Engl J Med; 2018 Oct; 379(16):1519-1528. PubMed ID: 30221595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
